No. of employees: About 400 locally and 850 globally
Top local officials:Amanda Wohlleber, site director of drug product operations in Wilmington, and Katie Schlipp, executive director of analytical services in Wilmington
Company description:Alcami Corp. is a Wilmington-headquartered contract development and manufacturing organization (CDMO) with expertise in drug development from discovery to commercialization.
Products made locally:Oral solid dosage drug products including tablets, hard-shell capsules and powders. Additional service offerings include analytical testing and development services of life-changing medications.
What made the company decide to make its goods locally?Amanda Wohlleber:“The people – our employees here in Wilmington have the passion and expertise to offer a unique value proposition of immense scientific talent and harmonious collaboration with our customers.”
What’s your target market?Wohlleber:“We are positioned to serve pharma and biotech companies of all sizes with the ability to stay nimble as the pharmaceutical landscape evolves.”
What’s planned next?Wohlleber:“We just completed a $2 million investment at our Wilmington headquarters to expand our oral solid development and manufacturing capabilities with the addition of a Gerteis Mini-Pactor roller compactor and low-humidity suites to our existing 140,000-square-foot campus in Wilmington. The expansion also builds out dry granulation capabilities and offers increased flexibility to support moisture-sensitive processes. Further expansions are planned in Wilmington as we continue to expand our oral solid dose manufacturing, packaging and analytical service offerings in Wilmington.”